Nadezhda V Antipova - JoVE Visualize

Showing results (11-20 of 18) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 18 results.

International Journal of Molecular Sciences|December 4, 2020

Establishment of Murine Hybridoma Cells Producing Antibodies against Spike Protein of SARS-CoV-2Nadezhda V Antipova, Tatyana D Larionova, Andrei E Siniavin, et al.

Medical Oncology (Northwood, London, England)|November 17, 2025

Temozolomide-induced senescent glioblastoma cells acquire sensitivity to TRAIL death receptor 5-mediated apoptosisAlina A Isakova, Diana V Mazur, Nadezhda V Antipova, et al.

Molecular & Cellular Proteomics : MCP|April 9, 2020

Investigation of Inter- and Intratumoral Heterogeneity of Glioblastoma Using TOF-SIMSSamvel K Gularyan, Alexander A Gulin, Ksenia S Anufrieva, et al.

International Journal of Biological Macromolecules|November 16, 2023

Dual targeting of DR5 and VEGFR2 molecular pathways by multivalent fusion protein significantly suppresses tumor growth and angiogenesisAlina A Isakova, Artem A Artykov, Ekaterina A Plotnikova, et al.

Cancers|February 24, 2024

The Nitro Group Reshapes the Effects of Pyrido[3,4-g]quinazoline Derivatives on DYRK/CLK Activity and RNA Splicing in Glioblastoma CellsSophia S Borisevich, Tatiana E Aksinina, Margarita G Ilyina, et al.

International Journal of Molecular Sciences|May 25, 2024

Correction: Yagolovich et al. DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against Glioblastoma. Int. J. Mol. Sci. 2022, 23, 12687Anne V Yagolovich, Alina A Isakova, Artem A Artykov, et al.

International Journal of Molecular Sciences|October 27, 2022

DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against GlioblastomaAnne V Yagolovich, Alina A Isakova, Artem A Artykov, et al.

Cancer Cell|June 26, 2018

Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing FactorsMarat S Pavlyukov, Hai Yu, Soniya Bastola, et al.

Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 18 results.

International Journal of Molecular Sciences|December 4, 2020

Establishment of Murine Hybridoma Cells Producing Antibodies against Spike Protein of SARS-CoV-2Nadezhda V Antipova, Tatyana D Larionova, Andrei E Siniavin, et al.

Medical Oncology (Northwood, London, England)|November 17, 2025

Temozolomide-induced senescent glioblastoma cells acquire sensitivity to TRAIL death receptor 5-mediated apoptosisAlina A Isakova, Diana V Mazur, Nadezhda V Antipova, et al.

Molecular & Cellular Proteomics : MCP|April 9, 2020

Investigation of Inter- and Intratumoral Heterogeneity of Glioblastoma Using TOF-SIMSSamvel K Gularyan, Alexander A Gulin, Ksenia S Anufrieva, et al.

International Journal of Biological Macromolecules|November 16, 2023

Dual targeting of DR5 and VEGFR2 molecular pathways by multivalent fusion protein significantly suppresses tumor growth and angiogenesisAlina A Isakova, Artem A Artykov, Ekaterina A Plotnikova, et al.

Cancers|February 24, 2024

The Nitro Group Reshapes the Effects of Pyrido[3,4-g]quinazoline Derivatives on DYRK/CLK Activity and RNA Splicing in Glioblastoma CellsSophia S Borisevich, Tatiana E Aksinina, Margarita G Ilyina, et al.

International Journal of Molecular Sciences|May 25, 2024

Correction: Yagolovich et al. DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against Glioblastoma. Int. J. Mol. Sci. 2022, 23, 12687Anne V Yagolovich, Alina A Isakova, Artem A Artykov, et al.

International Journal of Molecular Sciences|October 27, 2022

DR5-Selective TRAIL Variant DR5-B Functionalized with Tumor-Penetrating iRGD Peptide for Enhanced Antitumor Activity against GlioblastomaAnne V Yagolovich, Alina A Isakova, Artem A Artykov, et al.

Cancer Cell|June 26, 2018

Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing FactorsMarat S Pavlyukov, Hai Yu, Soniya Bastola, et al.

Pageof 2